QQ客服 官方微博 反馈留言

	Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes
	Zhang, Jingya; Zhang, Linna; Wang, Yuanyou; Zhao, Guisen
刊名	CANCER CHEMOTHERAPY AND PHARMACOLOGY
	2016
卷号	77期号:5页码:905-926
关键词	Angiogenesis Tumor RTKs Small molecule inhibitors Binding modes
DOI	10.1007/s00280-016-2961-6
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4764296
专题	山东大学
作者单位	Shandong Univ, Dept Med Chem, Key Lab Chem Biol, Minist Educ,Sch Pharmaceut Sci, Jinan 250100, Shandong,
推荐引用方式 GB/T 7714	Zhang, Jingya,Zhang, Linna,Wang, Yuanyou,et al. Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2016,77(5):905-926.
APA	Zhang, Jingya,Zhang, Linna,Wang, Yuanyou,&Zhao, Guisen.(2016).Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.CANCER CHEMOTHERAPY AND PHARMACOLOGY,77(5),905-926.
MLA	Zhang, Jingya,et al."Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes".CANCER CHEMOTHERAPY AND PHARMACOLOGY 77.5(2016):905-926.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。